New Delhi: Strides Arcolab on announced launch of the generic version of Hepatitis C drug 'Sofosbuvir' under the brand name 'Virso'.
The product will be available to Indian patients shortly, the Bangalore-based company said in a statement.
"In September 2014, Strides entered into a licensing agreement with
Gilead Sciences Inc to bring Hepatitis C cure to 91 developing
countries," Strides Arcolab said in a statement.
Labels: generic Sovaldi, India, Virso